Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

372 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Validation of tissue microarray technology in breast carcinoma.
Camp RL, Charette LA, Rimm DL. Camp RL, et al. Lab Invest. 2000 Dec;80(12):1943-9. doi: 10.1038/labinvest.3780204. Lab Invest. 2000. PMID: 11140706
Reduced alpha-catenin and E-cadherin expression in breast cancer.
Rimm DL, Sinard JH, Morrow JS. Rimm DL, et al. Lab Invest. 1995 May;72(5):506-12. Lab Invest. 1995. PMID: 7745946
Atypical reparative change on cervical/vaginal smears may be associated with dysplasia.
Rimm DL, Gmitro S, Frable WJ. Rimm DL, et al. Diagn Cytopathol. 1996 Jun;14(4):374-9. doi: 10.1002/(SICI)1097-0339(199605)14:4<374::AID-DC17>3.0.CO;2-H. Diagn Cytopathol. 1996. PMID: 8725141
Expression of c-met is a strong independent prognostic factor in breast carcinoma.
Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529
372 results
Jump to page
Feedback